UK group Cycle Pharma has made an unsolicited takeover bid ... of potential contingent value right (CVR) payments tied to sales levels of Vanda’s antipsychotic drug Fanapt (iloperidone), which ...

The pharmaceutical-sales field, often called "recession-proof," is popular because it offers excellent salary potential, great benefits, flexibility, opportunity for growth, and frequently the use of ...

After Novartis and Roche grew their sales last year, the Swiss pharma giants are handing their ... based stock plan for the 2024-2026 cycle. That item alone was worth $7.5 million, versus $5.9 ...